Zhao Bin, Wang Hui, Wang Yuzhu, Zhan Shen, Yu Pei
Beijing Haidian Hospital, Peking University, Beijing, China.
Tianjin Metabolic Diseases Hospital, Tianjin Medical University, Tianjin, China.
Front Med (Lausanne). 2024 Nov 14;11:1432437. doi: 10.3389/fmed.2024.1432437. eCollection 2024.
Early identification of autogenous arteriovenous fistula (AVF) maturation failure in patients with end-stage renal disease (ESRD) is crucial, as it enables early interventions that can enhance AVF maturation rates and reduce the duration of catheter use. This study aimed to identify factors that may predict arteriovenous fistula maturation in patients undergoing maintenance hemodialysis.
This retrospective study included a cohort of 532 ESRD patients who underwent AVF creation and routine follow-up at the Beijing Haidian Hospital (Haidian Section of Pecking University Third Hospital) from August 2018 to March 2022. A total of 532 patients were randomly divided into a training cohort (389 cases) and a validation cohort (143 cases). Patients in each cohort were categorized into mature and non-mature groups based on whether they met clinical or ultrasound criteria 3 months after AVF creation. The timing of early intervention for non-maturation AVF was preliminarily discussed after a risk prediction nomogram for non-maturation in newly AVF creation was constructed.
Of the 532 patients, 379 (73.24%) achieved fistula maturation at 3 months postoperatively. We randomly divided the total study population using computer-generated randomization into a training cohort ( = 389) and a validation cohort ( = 143) in an approximately 7:3 ratio. Analysis of the training cohort revealed that the anastomotic diameter (anas1), the internal diameter of the anastomotic vein (V1), brachial artery blood flow (F1) at 1 month, and brachial artery blood flow (F3) at 3 months postoperatively were associated with AVF maturation. A maturation nomogram was developed for the training cohort, yielding an area under the curve (AUC) of 0.938 (95% confidence interval [CI], 0.908-0.967), with a sensitivity of 0.911 and a specificity of 0.856. The model was validated in the validation cohort, showing an AUC of 0.927 (95% CI, 0.879-0.975), with a sensitivity of 0.870 and specificity of 0.886. The calibration curve showed strong agreement between nomogram predictions and actual observations.
The anastomotic diameter (anas1), the internal diameter of the anastomotic vein (V1), brachial artery blood flow (F1) at 1 month, and brachial artery blood flow (F3) at 3 months postoperatively can predict the unassisted maturation of AVF.
终末期肾病(ESRD)患者自体动静脉内瘘(AVF)成熟失败的早期识别至关重要,因为这能促使早期干预,从而提高AVF成熟率并缩短导管使用时长。本研究旨在确定可预测维持性血液透析患者动静脉内瘘成熟的因素。
这项回顾性研究纳入了2018年8月至2022年3月在北京海淀医院(北京大学第三医院海淀院区)行AVF造瘘术并接受常规随访的532例ESRD患者。总共532例患者被随机分为训练队列(389例)和验证队列(143例)。根据造瘘术后3个月是否符合临床或超声标准,将每个队列中的患者分为成熟组和未成熟组。在构建新造瘘AVF未成熟风险预测列线图后,初步探讨了对未成熟AVF进行早期干预的时机。
532例患者中,379例(73.24%)术后3个月实现内瘘成熟。我们使用计算机生成的随机数将整个研究人群按约7:3的比例随机分为训练队列(n = 389)和验证队列(n = 143)。对训练队列的分析显示,吻合口直径(anas1)、吻合静脉内径(V1)、术后1个月肱动脉血流量(F1)和术后3个月肱动脉血流量(F3)与AVF成熟相关。为训练队列制定了成熟列线图,曲线下面积(AUC)为0.938(95%置信区间[CI],0.908 - 0.967),灵敏度为0.911,特异度为0.856。该模型在验证队列中得到验证,AUC为0.927(95% CI,0.879 - 0.975),灵敏度为0.870,特异度为0.886。校准曲线显示列线图预测与实际观察结果高度一致。
吻合口直径(anas1)、吻合静脉内径(V1)、术后1个月肱动脉血流量(F1)和术后3个月肱动脉血流量(F3)可预测AVF无辅助情况下的成熟情况。